| Financial Year |
March 31 2023 |
| Monetary Funds |
5,333,229,981.45 |
| Held-for-trading Financial Assets |
929,266,241.82 |
| Notes Receivable |
5,302,044.30 |
| Accounts Receivable |
1,558,273,496.62 |
| Advances to Suppliers |
103,885,578.31 |
| Other Receivables |
63,669,104.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
715,601,499.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
234,923,678.72 |
| Total Current Assets |
8,948,074,329.54 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
18,357,898.31 |
| Long-term Equity Investment |
329,231,885.67 |
| Investment Properties |
-- |
| Fixed Assetes |
1,226,483,148.75 |
| Under-construction Projects |
815,434,621.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
397,279,277.79 |
| R&D expenses |
125,087,289.79 |
| Goodwill |
47,109,401.10 |
| Long-Term Deferred and Prepaid Expenses |
91,953,763.62 |
| Deferred Income Tax Assets |
246,116,518.86 |
| Other Non-Current Assets |
205,948,310.80 |
| Sub-Total of Non-Current Assets |
4,725,732,253.30 |
| Total Assets |
13,673,806,582.84 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
73,680,594.20 |
| Accounts Payable |
720,994,678.45 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
77,028,206.71 |
| Taxes Payable |
108,186,386.36 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
684,126,145.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
798,701,976.00 |
| Other Current Liabilities |
25,888,738.13 |
| Sub-Total of Current Liabilities |
3,278,575,292.91 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
31,913,885.04 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
170,143,749.22 |
| Total Liabilities |
3,448,719,042.13 |
| Paid-In Capital(Or Share Stock) |
413,914,325.00 |
| Capital Surplus |
4,489,669,848.80 |
| Surplus Reserve |
207,971,091.72 |
| LESS:Treasury Stock |
115,324,066.00 |
| Undistributed Profits |
4,982,714,416.15 |
| Minority Stockholder's Interest |
143,731,636.43 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,081,355,904.28 |
| Owner's Equity（Stockholder's Equity） |
10,225,087,540.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,673,806,582.84 |
